Reply to Auclin et al. Comment on “Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176”
Journal article published in 2021 by
Ashley M. Hopkins 
,
Ganessan Kichenadasse ,
Ahmad Y. Abuhelwa ,
Ross A. McKinnon ,
Andrew Rowland,
Michael J. Sorich
,
Ganessan Kichenadasse ,
Ahmad Y. Abuhelwa ,
Ross A. McKinnon ,
Andrew Rowland,
Michael J. Sorich
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
We thank Auclin et al. [...]